How AGEL SK Standardized ECG Decision Support Across 16 Locations

AGEL SK introduced PMcardio across its hospital network to support ECG interpretation and cardiac triage. With one catheterization laboratory in the network, clinicians needed decision support wherever patients first presented, particularly when a cardiologist was not immediately available.

Following an initial deployment in October 2024, AGEL SK made PMcardio for Organizations a network-wide standard in Q3 2025, reaching 16 locations and 11 department types. Platform data recorded 9,829 ECGs analyzed, 794 acute coronary occlusion findings, and 3,298 ECGs with an estimated left ventricular ejection fraction below 40%.

This case study shows how a nationwide hospital network brought AI-supported ECG interpretation to first-contact clinicians across departments.

What You'll Learn in the Full Case Study:

• How AGEL SK supported cardiac triage and transfer decisions with AI-assisted ECG interpretation
• How PMcardio reached 16 locations and 11 department types on existing devices
• How 9,829 ECG analyses yielded 794 acute coronary occlusion findings
• Why 83% of STEMI/STEMI-equivalent findings fell outside the 2 mm ST-elevation rule
• How LVsense^™ flagged 3,298 ECGs with an estimated ejection fraction below 40%

Outcome for Cardiologists

• Support for recognizing acute coronary occlusion with AI interpretation covering STEMI, STEMI equivalents, and OMI
• Additional decision support for first-contact clinicians when ECG findings are uncertain
• Support for PCI referral decisions at hospitals without an on-site catheterization laboratory
• Broader insight from the same ECG through LVsense^™ estimates of left ventricular function
• Consistent ECG decision support across 16 locations and 11 department types
• Sustained clinical use, with more than 700 ECGs analyzed monthly for nine consecutive months